Coagulation 6 Flashcards
Match each medication with its MOA.
Clopidogrel, warfarin, abciximab, enoxaparin
antithrombin cofactor, ADP receptor antagonist, vitamin K antagonist, GpIIB/IIIa receptor antagonist
clopidogrel- ADP receptor antagonist
warfarin- vitamin K antagonist
enoxaparin- antithrombin cofactor
Abciximab- GpIIb/IIIa receptor antagonist
Drugs that increase bleeding can be broken down into
antiplatelet drugs
anticoagulant drugs
fibrinolytics
Fibrinolytic drugs include
plasminogen activators
Plasminogen activators are
tPA
streptokinase
Anticoagulant drugs include
heparins
thrombin inhibitors
factor 10 inhibitors
vitamin K antaognists
tPA should be stopped _____ before procedures
1 hour
Streptokinase should be stopped ________ before procedures
3 hours
Heparin should be stopped
6 hours before procedures
LMWH should be stopped __________ before procedures
1-2 days
Warfarin should be stopped
2-4 days before procedures
Factor 10 inhibitors include
Fondaparinux
Fondaparinux should be stopped __________ before procedures
4 days
Thrombin inhibitors include
argatroban
bivalirudin
Arogatroban should be stopped
4-6 hours before
Bivalirudin should be stopped
2-3 hours before
Antiplatelet drugs include
ADP receptor inhibitors
GPIIb/IIIa receptor antagonists
Cox inhibitors (non-specific)
Cox 2 inhibitors
Examples of ADP receptor inhibitors include
clopidogrel
ticlopidine
prasugrel
ticagrelor
Ticagrelor & clopidogrel should be stopped
5-7 days before procedures
Ticlopidine should be stopped
14 days beforee
Prasugrel should be stopped
7-10 days
GpIIb/IIIa receptor antagonists include
abciximab
eptifabtide
tirofiban
Tirofiban & eptifabitide should be stopped
1 day before surgery
Abciximab should be stopped
3 days before surgery
Aspirin should be stopped
7 days before surgery
NSAIDs should be stopped
1-2 days before surgery
Celebrex should be stopped
doesn’t need to be!
Non-specific cox inhibitors work by
blocking COX-1 which stops the conversion of arachidonic acid to prostaglandins and ultimately thromboxane A2
COX 2 inhibitors affect on platelet function
they do not affect platelt function
Plasminogen activation inhibitors include
aminocaproic acid & tranexamic acid
Desmopressin stimulates
factor 8 and vWF factor release
Aprotinin inhibits
plasmin, thrombin, protein C, and kallikrein
TXA works on the
lysine binding sites on plasminogen
A patient scheduled for coronary revascularization is diagnosed with type 3 von Willebrand disease. What is the BEST treatment for this patient?
a. DDAVP
b. platelets
c. cryoprecipitate
d. vWF/factor 8 concentrate
d. vWF/factor 8 concentrate
The most common inherited disorder of platelet function is
Von Willebrand disease
Von Willebrand disease is a __________ platelet disorder
qualitative; platelet count is normal, but the platelets do not function properly
Lab abnormalities of Von Willebrand disease include
increased PTT and bleeding time
Von willebrand factor (MOA
anchors the platelet to the vessel wall at the site of vascular injury & carries inactivated factor 8 in the plasma
_______ & __________________ contain factors 8 and vFW and can be used for all 3 types of vFW disease
Cryo & FFP
The first-line agent for the patient with type 3 vWF disease is
Purified 8-vWF concentrate
Purified 8-vWF concentrate reduces the risk of
transfusion-related infection
Patients with type 1 vWF disease respond best to
desmopressin
Desmopressin stimulates the
release of endogenous vWF and increases factor 8 activity
Patients with type 3 vWF disease do not
respond to desmopressin b/c they don’t produce vWF
The desmopressin dose is
0.3 mcg/k IV
Von Willebrand factor is synthesized by
vascular endothelium and megakaryocytes
What are the three classifications of von Willebran disease?
type 1: mild-moderate reduction in the amount of vWF-produced
type 2: the vWF that is produced doesn’t work well
type 3: severe reduction in the amount of vWF produced
After using desmopressin, bleeding time is improved for
12-24 hours
Side effects of desmopressin include
vasodilation–> hypotension with rapid administration
hyponatremia d/t free water retention
What coagulating factors are in cryo?
fibrinogen
8 & 13
vWF